NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134,965 | +5.7% | 1,325 | +4.7% | 0.04% | +4.7% |
| Q2 2023 | $127,651 | +9.9% | 1,265 | +0.2% | 0.04% | +16.2% |
| Q1 2023 | $116,196 | -13.2% | 1,263 | -14.4% | 0.04% | -17.8% |
| Q4 2022 | $133,903 | +19.6% | 1,476 | 0.0% | 0.04% | +4.7% |
| Q3 2022 | $112,000 | -10.4% | 1,476 | 0.0% | 0.04% | -8.5% |
| Q2 2022 | $125,000 | +71.2% | 1,476 | +77.4% | 0.05% | +80.8% |
| Q1 2022 | $73,000 | +12.3% | 832 | +12.3% | 0.03% | +13.0% |
| Q4 2021 | $65,000 | -20.7% | 741 | -26.5% | 0.02% | -28.1% |
| Q3 2021 | $82,000 | -41.8% | 1,008 | -34.9% | 0.03% | -56.2% |
| Q2 2021 | $141,000 | +19.5% | 1,548 | +12.3% | 0.07% | +9.0% |
| Q1 2021 | $118,000 | +11.3% | 1,378 | +23.3% | 0.07% | +1.5% |
| Q4 2020 | $106,000 | +9.3% | 1,118 | 0.0% | 0.07% | -7.0% |
| Q3 2020 | $97,000 | -3.0% | 1,118 | -2.3% | 0.07% | -11.2% |
| Q2 2020 | $100,000 | +19.0% | 1,144 | +13.4% | 0.08% | -4.8% |
| Q1 2020 | $84,000 | – | 1,009 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |